Cargando…

Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?

Given the increasing incidence of neuroendocrine neoplasms (NENs) over the past few decades, a more comprehensive knowledge of their pathophysiological bases and the identification of innovative NEN biomarkers represents an urgent unmet need. There is still little advance in the early diagnosis and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giannetta, Elisa, La Salvia, Anna, Rizza, Laura, Muscogiuri, Giovanna, Campione, Severo, Pozza, Carlotta, Colao, Annamaria Anita LIvia, Faggiano, Antongiulio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339959/ https://www.ncbi.nlm.nih.gov/pubmed/34367064 http://dx.doi.org/10.3389/fendo.2021.672499

Ejemplares similares

Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues
por: Gallo, Marco, et al.
Publicado: (2021)

Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers
por: Giannetta, Elisa, et al.
Publicado: (2021)

Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches
por: Lania, Andrea, et al.
Publicado: (2021)

Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask
por: Albertelli, Manuela, et al.
Publicado: (2021)

Editorial—Special Issue: Foreword to the Special Issue on NIKE: Neuroendocrine Tumors, Innovation in Knowledge and Education
por: Faggiano, Antongiulio, et al.
Publicado: (2021)

Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications
por: Vitale, Giovanni, et al.
Publicado: (2021)

Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors
por: Barrea, Luigi, et al.
Publicado: (2021)

What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature
por: Giannetta, Elisa, et al.
Publicado: (2022)

A Novel MAX Gene Mutation Variant in a Patient With Multiple and “Composite” Neuroendocrine–Neuroblastic Tumors
por: Pozza, Carlotta, et al.
Publicado: (2020)

Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target
por: Modica, Roberta, et al.
Publicado: (2022)

Effect of Neuroendocrine Neoplasm Treatment on Human Reproductive Health and Sexual Function
por: Zamponi, Virginia, et al.
Publicado: (2022)

Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
por: Fanciulli, Giuseppe, et al.
Publicado: (2022)

Diabetes and Cancer
por: Colao, Annamaria, et al.
Publicado: (2011)

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness
por: Barrea, Luigi, et al.
Publicado: (2018)

Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management
por: Altieri, Barbara, et al.
Publicado: (2019)

Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors?
por: Barrea, Luigi, et al.
Publicado: (2021)

Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
por: Muscogiuri, Giovanna, et al.
Publicado: (2022)

Vitamin D and Cancer
por: Vuolo, Laura, et al.
Publicado: (2012)

Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?
por: Fanciulli, Giuseppe, et al.
Publicado: (2023)

Foreword to the special issue on advances in neuroendocrine neoplasms
por: Vitale, Giovanni, et al.
Publicado: (2021)

From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?
por: Vitale, Giovanni, et al.
Publicado: (2020)

Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review
por: La Salvia, Anna, et al.
Publicado: (2021)

Management of Functional Pancreatic Neuroendocrine Neoplasms
por: Magi, Ludovica, et al.
Publicado: (2023)

Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection
por: Altieri, Barbara, et al.
Publicado: (2023)

Commentary: Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management
por: Fanciulli, Giuseppe, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?
por: Di Molfetta, Sergio, et al.
Publicado: (2021)

Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature
por: Feola, Tiziana, et al.
Publicado: (2020)

Genetic-Clinical Profile of Subjects with Apparently Sporadic Extra-Adrenal Paragangliomas
por: Ramundo, Valeria, et al.
Publicado: (2012)

The Effects of Radioligand Therapy on Quality of Life and Sexual Function in Patients with Neuroendocrine Neoplasms
por: Malandrino, Pasqualino, et al.
Publicado: (2022)

Partitioning of Bronchopulmonary Carcinoids in Two Different Prognostic Categories by Ki-67 Score
por: Grimaldi, Franco, et al.
Publicado: (2011)

Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead
por: Colao, Annamaria, et al.
Publicado: (2020)

Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study
por: Modica, R., et al.
Publicado: (2022)

Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms
por: Zhuge, Xiaoling, et al.
Publicado: (2020)

Editorial: Neuroendocrine tumors: the road to precision medicine
por: La Salvia, Anna, et al.
Publicado: (2023)

Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors
por: Altieri, Barbara, et al.
Publicado: (2020)

Mediterranean Diet: What Are the Consequences for Menopause?
por: Vetrani, Claudia, et al.
Publicado: (2022)

Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs): A Systematic Review and Pooled Analysis
por: Arrivi, Giulia, et al.
Publicado: (2022)

Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma
por: Opalińska, Marta, et al.
Publicado: (2021)

DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms
por: Yao, James, et al.
Publicado: (2022)

Gastric Neuroendocrine Tumors (g-NETs): A Systematic Review of the Management and Outcomes of Type 3 g-NETs
por: Laffi, Alice, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_058g8a2epphbnevi0l0hjab071